Hans Keirstead

Hans Keirstead is a prominent leader in the biotechnology and medical research fields, currently serving as Chief Executive Officer of the Human Immunome Project, which focuses on creating immunological datasets and AI models for enhanced medical research. In addition, Hans holds significant roles as Chairman of the Board at Immunis, Inc. and AIVITA Biomedical, Inc., both of which concentrate on innovative treatments for immune-related conditions. Hans is actively involved in several charitable organizations, including serving as Chairman of the Board of Directors for the National Institute of Child Sexual Assault and Mission Plasticos. Educated at the University of Cambridge and the University of British Columbia, Hans possesses extensive expertise in neurobiology and cell biology.